Life science quality
trends report 2025
We asked 2000 global life science quality professionals to share their lessons, headaches, working styles and plans with us in our fourth annual survey.
What stood out…
Quality & compliance targets for 2025
43% of medical device companies aim to achieve EU MDR or IVDR compliance in 2025. Over a third of pharma and biotech companies have no new plans.
EU MDR/IVDR
43%
FDA 21 CFR 820
43%
ISO 13485
33%
ISO 14971
28%
ISO 27001
28%
None
19%
GMP
14%
ISO 14155
9%
ISO 9001
9%
GCP
0%
Other
5%
None
36%
GMP
32%
ISO 9001
19%
FDA QMM* Program
13%
ICH Qx
7%
ISO 17025
7%
ISO 15189
5%
PIC/S
5%
GCP
4%
ISO 27001
0%
Other
11%
Impact of an eQMS
Going digital pays off
3%
No
97%
Yes
18%
No
82%
Yes

Stats & metrics
Most common KPIs tracked by life science quality professionals
Documentation (read, signed, etc.)
74%
Non-conformances (closure time, outstanding, etc.)
74%
Training (completed, outstanding, etc.)
70%
Suppliers (RPPM, SCARs)
54%
Customer satisfaction (complaints, feedback, returns)
51%
Defects/faults
30%
Right-first-time %
23%
Rework/first pass yield
20%
Cost of poor quality (COPQ)
15%
None
7%
Other
4%
3-5
46%
10+
25%
1-2+
19%
6-9
10%
1-5
82%
6-10
8%
0
5%
11-15
2%
21+
2%
16-20
1%
Access the full report now
Fill out your details to see it in full!
